Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of commercial type 1 and type 2 PRRSV vaccines against heterologous dual challenge.

The Veterinary record - 19 Mar 2016

Choi K, Park C, Jeong J, Kang I, Park S-J, Chae C

Abstract excerpt

This study was to compare the effect of vaccination of pigs with either type 1 or type 2 porcine reproductive and respiratory syndrome virus (PRRSV) against heterologous dual challenge of both genotypes. Pigs were administered type 1 (UNISTRAIN PRRS) or type 2 (Fostera PRRS) PRRSV vaccine at 28 days of age and inoculated intranasally with both genotypes at 63 days of age. Vaccination of pigs with type 1 PRRSV was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Genotype
Share to Porcine Reproductive and Respiratory Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Porcine respiratory and reproductive syndrome virus

Share to Vaccination

Share to Viral gastroenteritis research and epidemiology

Share to Viral Vaccines

Source

Identifiers

PMID: 26864027
DOI: 10.1136/vr.103529

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of commercial type 1 and type 2 PRRSV vaccines against heterologous dual challenge.PMID 26864027Read ↗

Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.Semantic proximity Read ↗

Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing PigsSemantic proximity Read ↗

Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.Semantic proximity Read ↗

Comparison of Host Immune Responses to Homologous and Heterologous Type II Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Challenge in Vaccinated and Unvaccinated PigsSemantic proximity Read ↗

Efficacy of an intranasally administered live attenuated PRRSV-2 vaccine against challenge with a highly virulent PRRSV-1 strainSemantic proximity Read ↗

Simultaneous infection with porcine reproductive and respiratory syndrome and influenza viruses abrogates clinical protection induced by live attenuated porcine reproductive and respiratory syndrome vaccinationSemantic proximity Read ↗

Commercial PRRS Modified-Live Virus VaccinesSemantic proximity Read ↗

Comparison of protection provided by type 1 and type 2 porcine reproductive and respiratory syndrome field viruses against homologous and heterologous challengeSemantic proximity Read ↗

A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.Semantic proximity Read ↗

Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS).Semantic proximity Read ↗

Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigsSemantic proximity Read ↗

Efficacy test of a plant-based porcine circovirus type 2 (PCV2) virus-like particle vaccine against four PCV2 genotypes (2a, 2b, 2d, and 2e) in pigs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.